Parkinson’s disease therapy safinamide launches in the UK
23 May 2016 | By Victoria White, Digital Content Producer
Commenting on the launch, Maurizio Castorina, CEO of Zambon, said safinamide offers PD patients "a novel therapeutic option"...
List view / Grid view
23 May 2016 | By Victoria White, Digital Content Producer
Commenting on the launch, Maurizio Castorina, CEO of Zambon, said safinamide offers PD patients "a novel therapeutic option"...
18 May 2016 | By Mandy Parrett, Editorial Assistant
Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.